For each analysis in Table 2 and for the unmatched analysis of MOF, we also present Kaplan-Meier survival curves for crude illustrations ( Figure 2 ), which yielded non-significant results in all analyses of the matched cohort
682-P: Novel dual glucagon and glucagon-like peptide-1 receptor agonist LY3305677 improves glucose control, reduces body weight, and increases energy expenditure in mice
View FDA DMF Filings in Q1 2025 (Power BI Dashboard, Free Excel Available) Our view Given Trumps rhetoric around tariffs on imported drugs, the record-breaking DMF submissions in Q1 2025 sent out a strong message that the global pharmaceutical industry is willing to take on the complex geopolitical situation with resilience and strategic foresight
Why GLP-1 pills could be a game-changer Several oral GLP-1 pills are in late-stage development and theyre getting closer to hitting the market
Glutathione is generally well-tolerated by most adults, but some individuals may experience mild digestive upset when first starting
This measurement reflects kidney failure